249 related articles for article (PubMed ID: 31588877)
1. A stepwise approach to implementing pharmacogenetic testing in the primary care setting.
Weitzel KW; Duong BQ; Arwood MJ; Owusu-Obeng A; Abul-Husn NS; Bernhardt BA; Decker B; Denny JC; Dietrich E; Gums J; Madden EB; Pollin TI; Wu RR; Haga SB; Horowitz CR
Pharmacogenomics; 2019 Oct; 20(15):1103-1112. PubMed ID: 31588877
[TBL] [Abstract][Full Text] [Related]
2. Implementation of wide-scale pharmacogenetic testing in primary care.
Natasha Petry ; Baye J; Aifaoui A; Wilke RA; Lupu RA; Savageau J; Gapp B; Massmann A; Hahn D; Hajek C; Schultz A
Pharmacogenomics; 2019 Aug; 20(12):903-913. PubMed ID: 31453774
[TBL] [Abstract][Full Text] [Related]
3. Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.
Weitzel KW; Cavallari LH; Lesko LJ
Pharm Res; 2017 Aug; 34(8):1551-1555. PubMed ID: 28466392
[TBL] [Abstract][Full Text] [Related]
4. Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
Chang WC; Tanoshima R; Ross CJD; Carleton BC
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():65-84. PubMed ID: 33006916
[TBL] [Abstract][Full Text] [Related]
5. Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings.
Cicali EJ; Weitzel KW; Elsey AR; Orlando FA; Vinson M; Mosley S; Smith DM; Davis R; Drum L; Estores D; Franciosi JP; Hagen MG; Jerkins GJ; Mercado ES; Nainaparampil J; Padron A; Rosenberg EI; Wright A; Schmidt SO; Mathews CA; Cavallari LH; Johnson JA
Genet Med; 2019 Oct; 21(10):2264-2274. PubMed ID: 30926959
[TBL] [Abstract][Full Text] [Related]
6. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
[TBL] [Abstract][Full Text] [Related]
7. Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.
Haga SB; Mills R; Moaddeb J; Allen LaPointe N; Cho A; Ginsburg GS
Pharmacogenomics; 2017 Mar; 18(4):359-367. PubMed ID: 28244812
[TBL] [Abstract][Full Text] [Related]
8. Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands.
Bank PCD; Swen JJ; Guchelaar HJ
BMC Med; 2019 Jun; 17(1):110. PubMed ID: 31196067
[TBL] [Abstract][Full Text] [Related]
9. The challenges of implementing pharmacogenomic testing in the clinic.
Moyer AM; Caraballo PJ
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
[TBL] [Abstract][Full Text] [Related]
10. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
[TBL] [Abstract][Full Text] [Related]
11. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
[TBL] [Abstract][Full Text] [Related]
12. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
Bousman C; Maruf AA; Müller DJ
Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
[TBL] [Abstract][Full Text] [Related]
13. The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
Dias MM; Sorich MJ; Rowland A; Wiese MD; McKinnon RA
Pharm Res; 2017 Aug; 34(8):1544-1550. PubMed ID: 28236061
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models.
Hayward J; McDermott J; Qureshi N; Newman W
Pharmacogenomics; 2021 Aug; 22(12):761-776. PubMed ID: 34467776
[TBL] [Abstract][Full Text] [Related]
15. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
[No Abstract] [Full Text] [Related]
16. Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.
Roden DM; Van Driest SL; Mosley JD; Wells QS; Robinson JR; Denny JC; Peterson JF
Clin Pharmacol Ther; 2018 May; 103(5):787-794. PubMed ID: 29377064
[TBL] [Abstract][Full Text] [Related]
17. Advancing precision medicine in healthcare: addressing implementation challenges to increase pharmacogenetic testing in the clinical setting.
Dong OM; Wiltshire T
Physiol Genomics; 2017 Jul; 49(7):346-354. PubMed ID: 28550089
[TBL] [Abstract][Full Text] [Related]
18. Individualizing pharmacogenomic test results in the context of the microbiome.
Haga SB
Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284
[TBL] [Abstract][Full Text] [Related]
19. Patient insights on features of an effective pharmacogenomics patient portal.
Truong TM; Lipschultz E; Schierer E; Danahey K; Ratain MJ; O'Donnell PH
Pharmacogenet Genomics; 2020 Dec; 30(9):191-200. PubMed ID: 33017129
[TBL] [Abstract][Full Text] [Related]
20. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
